# Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation

> **NCT06840262** · NA · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 45 (estimated)

## Conditions studied

- Amputation

## Interventions

- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Regenerative Peripheral Nerve Interface Surgery
- **PROCEDURE:** Targeted Muscle Reinnervation

## Key facts

- **NCT ID:** NCT06840262
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-10
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-02-02
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06840262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06840262, "Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06840262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*